Myeloperoxidase (MPO) Gene Polymorphism Confers Cirrhotic Patients with Hepatopulmonary Syndrome

Jing Yu; Bing Quan Zhang; Na Zhang; Yan Ying Wang; Ya Juan Zhai; Wen Bing Wang

doi:10.4028/www.scientific.net/AMR.183-185.1307

Paper Titles

Study on the Application of Small-Size Wireless Network Infrastructure in the Reform of Modern Means of Education
p.1287

Research of Faith in E-Commerce Safety
p.1292

Study on the Application of Small-Size Wireless Network in Modern Model of Education
p.1297

Application & Research of Multi-Media Network Technology in Chemistry Experimental Course
p.1302

Myeloperoxidase (MPO) Gene Polymorphism Confers Cirrhotic Patients with Hepatopulmonary Syndrome
p.1307

Comparative Study of Ozone Alone and Catalytic Ozonation for Transformation of Natural Organic Matter in River Water
p.1312

Benthic Assemblages and their Relationships with Water Quality Measures in the Songhua River, Northeast China
p.1317

Construction of the Food Safety System Based on the Internet Monitoring System
p.1322

The Applications of Vision Technology in Food Processing
p.1327

HomeAdvanced Materials ResearchAdvanced Materials Research Vols. 183-185Myeloperoxidase (MPO) Gene Polymorphism Confers...

Myeloperoxidase (MPO) Gene Polymorphism Confers Cirrhotic Patients with Hepatopulmonary Syndrome

Abstract:

In this study,we investigated the–463G/A promoter polymorphism of the MPO gene,in an attempt to explore the role of MPO in the pathogenesis of HPS caused by cirrhosis.The polymorphism of the MPO gene means the individual genotypes have different initial mRNA transcription activities and different expression levels,which further influences the activities of enzymes and results in the variation in disease susceptibility.This paper addresses gene polymorphisms play a key role in the development of HPS in cirrhotic patients.

You might also be interested in these eBooks

Environmental Biotechnology and Materials Engineering

View Preview

Info:

Periodical:

Advanced Materials Research (Volumes 183-185)

Pages:

1307-1311

DOI:

https://doi.org/10.4028/www.scientific.net/AMR.183-185.1307

Citation:

Cite this paper

Online since:

January 2011

Authors:

Jing Yu, Bing Quan Zhang, Na Zhang, Yan Ying Wang, Ya Juan Zhai, Wen Bing Wang

Keywords:

Hepatopulmonary Syndrome, Myeloperoxidase, Polymorphism

Export:

RIS, BibTeX

Price:

Permissions CCC:

Request Permissions

Permissions PLS:

Request Permissions

Сopyright:

Citation:

References

[1] Fallon MB. Mechanisms of pulmonary vascular complications of liver disease: hepatopulmonary syndrome. J Clin Gastroenterol, 2005, 39: S138–S142.

DOI: 10.1097/01.mcg.0000155570.19340.61

Google Scholar

[2] Zhang XJ, Katsuta Y, Akimoto T, et al. Intrapulmonary vascular dilatation and nitric oxide in hypoxemic rats with chronic bile duct ligation. J Hepatol, 2003, 39: 724-730.

DOI: 10.1016/s0168-8278(03)00430-6

Google Scholar

[3] Mossman BT, Churg A. MechanAsms An the pathogenesAs of as2 bestosAs and sAlAcosAs. A m J RespA r CrAt Care Med, 1998, 157: 1666.

Google Scholar

[4] Hypochlorite and hypobromite with reference to inflammation-associated carcinogenesis. Cancer Lett, 2002, 178: 37-42.

Google Scholar

[5] Whiteman M, Spencer JP, Jenner A, et al. Hypochlorous acid-induced DNA base modification: potentiation by nitrite: biomarkers of DNA damage by reactive oxygen species. Biochem. Biophys. Res. Commun, 1999, 257: 572-576.

DOI: 10.1006/bbrc.1999.0448

Google Scholar

[6] Eiserich JP, Baldus S, Bronnan ML, et al. Myeloporoxidase, a leukocyte-derived vascular NO oxidase[J]. Seienee, 2002, 296(5577): 2391-2394.

Google Scholar

[7] Baldus S, Eiserieh JP, Mani A, et al. Endothelial transey tosis of myeloPeroxidase confers specifieity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest, 2001, 108: 1759-1770.

DOI: 10.1172/jci200112617

Google Scholar

[8] Abu-Soud HM, Khassawneh MY, Sohn JT, et al. Peroxidases inhibit nitri Coxide(NO) dependent bronehodilation: development of a model deseribing NO-Peroxidase interactions. Bioehemistry, 2001, 40: 11866-11875.

DOI: 10.1021/bi011206v

Google Scholar

[9] Zhang C, PatelR, Eiserich JP, et al. Endothelial dysfunction is induced by Proinflammatory oxidant hyPoehlorous acid. Am J Physiol Heart Cire Physiol, 2001, 281: al. H1469-H1475.

DOI: 10.1152/ajpheart.2001.281.4.h1469

Google Scholar

[10] Zhang C, Reiter C, Eiserieh JP, et al. L-Arginine chlorine ation products inhibit endothelial nitric oxide produetion. J Biol Chem, 2001, 276: 27159-27165.

Google Scholar

[11] Austin GE, Lam L, Zaki SR, et al. Sequence comparison of putative regulatory DNA of 5' flanking region of the myeloperoxidase gene in normal and leukemic bone marrow cells. Leukemia, 1993, 7: 1445-1450.

Google Scholar

[12] Piedrafita FJ, Molander RB, Vansant Q, et al. An Alu element in the myeloperoxidase promoter contains a composite SP 1-thyroid hormone-retinoic acid response element.J. Biol. Chem, 1996, 271: 14412-14420.

DOI: 10.1074/jbc.271.24.14412

Google Scholar